Human Subjects Research and Ethics Part 2
It covers topics such as public vs. private information, definitions of research with human subjects, Institutional Review Board (IRB) responsibilities, informed consent, vulnerable populations, exempt and expedited research review, and risk assessment in behavioral and biomedical studies. This is ideal for students, researchers, or professionals preparing for human subjects research certification or IRB training.
Amendments involving changes to IRB-approved protocols do NOT need prior IRB approval if:
The changes must be immediately implemented for the health and well-being of the subject.
Key Terms
Amendments involving changes to IRB-approved protocols do NOT need prior IRB approval if:
The changes must be immediately implemented for the health and well-being of the subject.
IRB continuing review of a greater than minimal risk approved protocol that is currently enrolling subjects must:
Occur at least annually.
A 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy. While the study is on-going, a new drug becomes commercially available that may have equal or greater benefit to the subject. The investigator should do which of the following?
Give the subject comprehensive information about the new drug, including its side effects. Discuss the pros and cons of both the investigational dr...
The purpose of informed consent is:
To provide a potential subject with appropriate information in an appropriate manner and allow that person to make an informed decision about parti...
A general requirement for the informed consent form is that it may not include any exculpatory language. Exculpatory language is that which waives or appears to waive any of the subject's legal rights or releases or appears to release those conducting the research from liability for negligence. Which of the following statements in a consent form is an example of exculpatory language?
I waive any possibility of compensation for injuries that I may receive as a result of participation in this research.
An investigator is confronted with a life-threatening situation that necessitates using a test article in a human subject who is unable to provide informed consent and there is no time to obtain consent from the individual's LAR and no alternative method or recognized therapy is available. Under the FDA regulations for using test articles, which of the following describes the best course of action for the investigator:
The investigator and an independent physician agree that the situation necessitates the use of the test article. An exception or waiver for informe...
Related Flashcard Decks
Study Tips
- Press F to enter focus mode for distraction-free studying
- Review cards regularly to improve retention
- Try to recall the answer before flipping the card
- Share this deck with friends to study together
Term | Definition |
---|---|
Amendments involving changes to IRB-approved protocols do NOT need prior IRB approval if: | The changes must be immediately implemented for the health and well-being of the subject. |
IRB continuing review of a greater than minimal risk approved protocol that is currently enrolling subjects must: | Occur at least annually. |
A 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy. While the study is on-going, a new drug becomes commercially available that may have equal or greater benefit to the subject. The investigator should do which of the following? | Give the subject comprehensive information about the new drug, including its side effects. Discuss the pros and cons of both the investigational drug and the commercially available drug and then allow the subject to decide whether to withdraw from the research to take the new drug. |
The purpose of informed consent is: | To provide a potential subject with appropriate information in an appropriate manner and allow that person to make an informed decision about participation in research. |
A general requirement for the informed consent form is that it may not include any exculpatory language. Exculpatory language is that which waives or appears to waive any of the subject's legal rights or releases or appears to release those conducting the research from liability for negligence. Which of the following statements in a consent form is an example of exculpatory language? | I waive any possibility of compensation for injuries that I may receive as a result of participation in this research. |
An investigator is confronted with a life-threatening situation that necessitates using a test article in a human subject who is unable to provide informed consent and there is no time to obtain consent from the individual's LAR and no alternative method or recognized therapy is available. Under the FDA regulations for using test articles, which of the following describes the best course of action for the investigator: | The investigator and an independent physician agree that the situation necessitates the use of the test article. An exception or waiver for informed consent can be made under these circumstances. The IRB will be notified later. |
An elderly gentleman, whose wife is his legally authorized representative (LAR) since his strokes several years ago, was recently diagnosed with lung cancer. He is eligible for a clinical trial using a new investigational drug that aims to treat lung cancer. He is able to express interest, shows a basic understanding of the nature of the trial, and gives his assent to participation. The subject's wife is out of town on a business trip. | Send a copy of the informed consent via facsimile to the subject's wife. After she has had the opportunity to speak to the investigator, she can sign the informed consent and fax it back. |
A researcher is conducting a written survey about people's attitudes toward walking as an exercise option at the local shopping mall that supports a walking program. The survey is anonymous (without codes, names, or other information) and subjects may complete the survey and place it in a box at the shopping mall exits. Which of the following is the most important issue that the researcher addressed in planning the research? | Confidentiality of the individual subject's responses |
A researcher wants to invite therapists to participate in small focus groups to discuss their perceptions regarding "troubled" adolescent girls and the relationships they have with their parents. Specific clients of the therapists will not be discussed. Which of the following will be the most important issue for the researcher to consider when planning the research? | Breach of confidentiality from the focus group subjects (therapists) |
Which of the following most accurately describes the risks associated with SBR? | Less predictable, more variable, and less treatable than physical harms |
Which of the following is considered a SBR data collection method? | Interviews |
In order to grant a waiver or alteration of the requirements of informed consent, an IRB must find which of the following: | The research could not practicably be carried out without the waiver of consent. |
A researcher wants to conduct a secondary analysis using a Centers for Disease Control and Prevention (CDC) database that was collected by the agency solely for surveillance purposes from 1996-2006. The researcher did not participate in the initial collection of the data. The database is publicly available. The database does not include any identifiers. The IRB makes a determination that the individuals whose records will be reviewed do not meet the federal definition of human subjects. | The researcher will not be interacting/intervening with subjects and the data has no identifiers. |
An investigator obtains consent and HIPAA authorization from subjects to review their medical records and HIV status. He plans to go back to the medical record, so the HIV status information is stored along with subject identifiers in a database that he keeps on his laptop computer. His laptop is stolen. This incident constitutes: | A breach of confidentiality |
Identify the following groups that are protected in the federal regulations (45 CFR 46), specifically in Subparts B, C, and D with additional protections: | Pregnant women, prisoners, children |
In considering NBAC's analytic approach, an otherwise competent person who is acutely ill might be considered at especially high risk of harm for: | Situational cognitive vulnerability |
Which is an example of a situation where deferential vulnerability might be a factor? | A physician recruiting patients to be subjects |
According to the authors, there are four common abuses that historically are described as giving rise to vulnerability. Which response below contains the correct four? | Physical control, coercion, undue influence, and manipulation |
Subjects with a serious illness may be at risk for exploitation because they may be desperate for a possible cure. This is an example of: | Medical vulnerability |
A federally funded research study involving children 8 to 12 years old involves collecting a single voided urine sample to assess the frequency of asymptomatic proteinuria (higher amounts of protein in the urine without any signs or symptoms of illness or infection). Your IRB has determined that assent of children age 8 and older is required for the study. A 10-year-old firmly declined to participate in the study described above. Which of the following procedures best describes the action to be taken by the investigator? | Honor the child's decision. |
A federally funded research study involving children 8 to 12 years old involves collecting a single voided urine sample to assess the frequency of asymptomatic proteinuria (higher amounts of protein in the urine without any signs or symptoms of illness or infection). According to 45 CFR 46, an IRB's risk assessment would likely conclude that this study involves: | No more than minimal risk to the child. |
An investigator proposes a study to determine the clinical relevance of a new assay technique to measure minimal residual disease (MRD) in adolescent (age 14-16) cancer patients undergoing chemotherapy. The study requires that two additional bone marrow aspirates be performed during the course of chemotherapy. The subject's chemotherapy will not be altered based on the results of the assay technique measures. However, future patients with cancer would benefit from improved interventions based on study findings. The IRB determined that the activity was a minor increase over minimal risk. Which of the following statements best describes the IRB approval requirements for involving adolescent cancer patients in the research study? | Assent of the child and permission of both parents are required. |
The results from research have been known to produce harms to members of the sampled population who do not actually participate in the research study. An example of the type of research that could result in group harms by stigmatizing members of the group (even for individuals who do not participate in the research) is: | A study of the types and prevalence of sexually transmitted infections (STIs) in small rural towns in a midwestern state. |
Which of the following practices can be effective in minimizing group harms? | - Collaborative IRB review- Ongoing consultation- Planning disclosure of research results- Community consultation |
Which of the following studies has the LEAST potential to create group harm? | A Phase 3 clinical trial of a new anticancer agent in middle-aged women diagnosed with breast cancer. |
A sponsor proposes research to evaluate reengineering a commercially available pacemaker. It is hoped that the new pacemaker will pose fewer risks to individuals when compared to the current commercially available product. How should this device be classified? | Significant risk device |
An adult with attention deficit hyperactivity disorder (ADHD) presents to a physician. To date, no behavioral or drug interventions have proven useful. The physician has just read several reports about a drug that is approved and marketed for another indication, but has shown some benefit for ADHD. The physician wants to prescribe this drug, in the labeled marketed dose, for the individual patient. Which of the following would be the most appropriate course of action? | Treat the patient with the drug based on physician's best medical judgment |
An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12. The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children. Which of the following is the investigator's most appropriate course of action? | Submit the research protocol to the IRB for review and submit an IND application to the FDA before conducting the research |
The FDA's regulations related to electronic records and electronic signatures (21 CFR Part 11) are intended to: | Allow the use of electronic documents and signatures in the regulatory process for drugs and devices. |
An academic medical center is selecting a new database system for clinical research. The system needs to be "Part 11 compliant" in order to allow: | The medical center to replace the use of paper records with electronic records for its research. |
A Data Safety Monitoring Board report for an investigator-initiated investigational drug study indicates a significantly higher than anticipated rate of an expected adverse event. This event required revision of the informed consent form to disclose the higher rate. A change in the eligibility criteria of the protocol to reduce the risk was implemented. Current subjects would be reconsented. | This is an unanticipated problem. |
Housekeeping employees of the medical center were recruited for a federally funded study of blood pressure, blood count levels, infectious disease history, and job stress. The interviews and blood tests were conducted in a private location not affiliated with the study center. Follow-up interviews were conducted in the same location. The study coordinator stopped at the cafeteria on her way back to the study office after the second study visit for the last three study subjects and lost the three file folders. Records of one subject indicated he had a history of a sexually transmitted disease and another had recently been treated for tuberculosis. The subjects were notified of the loss. Following this event, the IRB approved a protocol change requiring that all records be transmitted electronically to the study office using the medical center's secure network. | This is an unanticipated problem and not an adverse event. |
A subject received the wrong study drug resulting in severe nausea and vomiting, and a visit to the emergency room for treatment. The subject notified the study coordinator the day after the emergency room visit. The study coordinator reviewed the subject's study records and discovered the error. The coordinator notified the subject of the study drug error, which caused the nausea and vomiting. The investigator notified the IRB and the IRB approved a revision of the standard pharmacy procedure for administering investigational drugs. | This is an unanticipated problem, which resulted in an adverse event. |
A study requires that each subject be given two study drugs. The first study drug is given on Day 1. A second study drug is given on Day 7 to counteract the toxicity of Drug 1. Subject # 4-706 is given Drug 1 on Day 1. Due to a snowstorm, Subject 4-706 is delayed for several days before returning to the site for Drug 2. Missing the administration of Drug 2 on Day 7 placed the subject at risk of significant toxicity. This event required the subject be notified of the increased risk and required close monitoring of the subject by phone. | This is an unanticipated problem that does not include an adverse event. |
An investigational biologic administered to the first two subjects in a Phase II clinical trial was not appropriately screened for two viral contaminants, HIV and Hepatitis B, due to human error in the screening process. Follow-up testing indicated that the subjects and their partners were not infected. The subjects and others were notified of the increased risk. | This is an unanticipated problem requiring notification to the IRB and FDA. |
Under HIPAA, a "disclosure accounting" is required: | For all human subjects research that uses PHI without an authorization from the data subject, except for limited data sets. |
Under HIPAA, "retrospective research" (a.k.a., data mining) on collections of PHI generally ... | Is research, and so requires either an authorization or meeting one of the criteria for a waiver of authorization. |
HIPAA's protections for health information used for research purposes... | Supplement those of the Common Rule and FDA. |
A covered entity may use or disclose PHI without an authorization, or documentation of a waiver or an alteration of authorization, for all of the following EXCEPT: | Data that does not cross state lines when disclosed by the covered entity. |
If you're unsure about the particulars of HIPAA research requirements at your organization or have questions, you can usually consult with: | An organizational IRB or Privacy Board, privacy official ("Privacy Officer"), or security official ("Security Officer"), depending on the issue. |
The FDA regulations governing disclosure of individual COIs require: | Applicants submitting marketing applications to disclose financial COIs of researchers who conducted clinical studies |
An example of an institutional COI is: | An industry sponsor pays for the construction of a new research laboratory at the organization |
A researcher's membership on an advisory board with an organization sponsoring research can create a COI because: | It may be difficult for the researcher to appear neutral, as the researcher may have an interest in the research's success |
During an Institutional Review Board (IRB) meeting, any IRB member who may have a potential COI with a study under review should: | Disclose their potential COI and may answer questions, but recuse themselves from voting |
The COI management plan aims to: | Provide procedures or extras steps to be taken to minimize the risk of bias when a COI is disclosed |
Under the U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) regulations, what is the Institutional Review Board (IRB) charged with? Select all that apply. | - Protecting the rights and welfare of human subjects.- Assuring that researchers follow all applicable institutional policies and federal regulations related to research with human subjects.- Reviewing subject recruitment materials and strategies. |
A student is conducting a research project that involves the use of a survey. The survey asks subjects about their highest level of education, political affiliation, and views on various social issues. The student will not collect identifiable information. This study would be subject to which type of review? | Determination for Exemption |
In the U.S., the first federal regulations for human subjects research began in 1981 with the codification of the ________. | Common Rule |
Identify one way faculty researchers can possibly avoid undue influence of student subjects? | Avoid recruiting their own students in the research |
A graduate student needs to conduct a research project for her master's thesis. She is interested in the types of junk food available to the public. She plans to go to the local convenience stores and ask the owners what types of junk food the store normally stocks, and which are the biggest sellers. She will not collect identifiers. This study would be subject to which type of review? | Not Human Subjects |
A research project is designed to evaluate a new experimental type of fetal surgery to correct diaphragmatic hernia in the fetus (a potentially life-threatening condition for the baby) prior to delivery. This research is directed toward the fetus as subject to meet the health needs of the fetus. The pregnant woman is otherwise healthy. The investigator must obtain consent from whom? | The pregnant woman and the father of the fetus. |
According to current NIH Guidelines, which of the following is adequate justification for exclusion of women from NIH-funded research? | There is compelling evidence that inclusion would be inappropriate with respect to the health of the subjects. |
Investigators wish to evaluate a new treatment for eclampsia (a life-threatening condition in pregnant women) in women 30 - 50 years of age. The research is intended to directly benefit the pregnant woman who is otherwise healthy and competent. The investigator must obtain consent from whom? | The pregnant woman only. |
A convened IRB Committee approved a protocol as a more than minimal risk study on February 15, 2019. In 2020, the study remains open to enrollment with 14 subjects currently enrolled and receiving the intervention. Which of the following best describes IRB continuation review requirements for this study? | The research must be re-reviewed by the convened IRB on or before February 14, 2020. |
During the course of a study, the researcher reports to the IRB that the consent form needs to be changed to reflect her new contact information. Who can approve this change? | The chair of the IRB |
A full IRB committee meeting is convened and one agenda item is a new research proposal to evaluate how mothers interact with their learning-disabled child. The inclusion criteria require the children to be a minimum of five years of age. The protocol requires the mother of the child to look at the child without any expression and not to talk to the child for three minutes. The committee determined that the mother's required task may upset the child. The IRB approved the study with appropriate language in the parental permission form regarding the possibility that children might become upset. | Nothing |
A full IRB committee meeting is convened. The IRB committee roster consists of 15 members. However, only 8 members are in attendance for today's meeting. One of the IRB members is Principal Investigator for one of the studies being reviewed and receives a portion of her salary from the supporting grant. | Defer the proposal to the next meeting because of a loss if quorum. |
A full IRB committee meeting is convened and one agenda item is a new research proposal to evaluate how mothers interact with their children with learning disabilities. The inclusion criteria require the children to be a minimum of five years of age. The protocol requires the mother of the child to look at the child without any expression and not to talk to the child for three minutes. | Table the protocol and ask the investigator to provide the needed information for review by the full board at the next convened meeting. |